Hiroyuki Yanai

ORCID: 0000-0002-9989-5144 · 4 papers in corpus
review 2022
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15426

AIM: Histopathologic diagnosis of a subset of uterine smooth muscle tumors is challenging. We report a critical review regarding the clinicopathological point of view of 62 cases of subsequently recurred or metastasized leiomyoma. METHODS:…

case-report 2022
Biomedicines ·doi:10.3390/biomedicines10030547

Ovarian tumors include neoplasms derived from somatic cells and germ cells, including teratoma. Sometimes, tumors of the somatic cell type may develop from teratoma, causing diagnostic perturbation. We experienced a case of a tumor composed…

guideline 2018
International journal of clinical oncology ·doi:10.1007/s10147-017-1193-z

BACKGROUND: Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncolog…

observational 2015
Medical molecular morphology ·doi:10.1007/s00795-014-0090-z

Ovarian clear cell adenocarcinoma (CCA) has been believed to be a lethal histological subtype of an epithelial ovarian adenocarcinoma (EOA); its precursor has been assumed to be endometriosis. However, it has been reported that CCAs occasio…